142 related articles for article (PubMed ID: 7598033)
1. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
Nakano S; Kawamura J
Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of cellular proliferation in renal cell carcinoma: a comparison of synthesis-phase fraction and proliferating cell nuclear antigen index.
Grignon DJ; Abdel-Malak M; Mertens W; Koster J; Keeney M; Sakr W; Shepherd RR
Mod Pathol; 1995 Jan; 8(1):18-24. PubMed ID: 7731937
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
8. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
10. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
Cheville JC; Terrell RB; Cohen MB
Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
12. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
13. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
14. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
Lehmann J; Retz M; Nürnberg N; Schnöckel U; Raffenberg U; Krams M; Kellner U; Siemer S; Weichert-Jacobsen K; Stöckle M
Cancer; 2004 Oct; 101(7):1552-62. PubMed ID: 15378494
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma.
Morell-Quadreny L; Clar-Blanch F; Fenollosa-Enterna B; Perez-Bacete M; Martinez-Lorente A; Llombart-Bosch A
Anticancer Res; 1998; 18(1B):677-82. PubMed ID: 9584051
[TBL] [Abstract][Full Text] [Related]
17. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
19. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of PCNA in renal pelvic and ureteral cancer].
Kong C; Li Z; Liu T
Zhonghua Wai Ke Za Zhi; 1996 Oct; 34(10):614-6. PubMed ID: 9590738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
